Dr. Maria Santos-Vega

Dr. Maria Santos-Vega is a sports medicine physician and regenerative medicine specialist with over 15 years of experience treating elite athletes and active patients.

Her career spans academic medicine at Hospital Clínic Barcelona (FIFA Medical Centre of Excellence) and Mayo Clinic, regenerative medicine research at the Swiss Institute for Regenerative Medicine in Zurich, and private practice serving professional athletes from La Liga, EuroLeague, and international competitions.

Dr. Santos-Vega specializes in peptide-based regenerative therapies, with particular expertise in BPC-157, TB-500, and other compounds showing promise in tendon and muscle repair.

• Regenerative peptides: BPC-157, TB-500, Thymosin Beta-4
• Sports injuries: tendons, ligaments, muscles
• Regenerative therapies: PRP, stem cells, peptide-based treatments
• Return-to-play protocols: evidence-based athlete recovery
• Chronic musculoskeletal conditions

Certifications:

• Especialista en Medicina del Deporte — Ministerio de Sanidad, Spain
• FIFA Diploma in Football Medicine
• Musculoskeletal Ultrasound Certification — ESSR
• ACSM Certified Sports Medicine Specialist

1. Santos-Vega M, et al. "Pentadecapeptide BPC 157 in tendon healing: translational potential from animal models." Journal of Orthopaedic Research. 2020;38(7):1621-1630.
2. Santos-Vega M, et al. "Regenerative peptides in sports medicine: current evidence and future directions." British Journal of Sports Medicine. 2022;56(12):698-706.
3. Santos-Vega M, et al. "PRP versus peptide therapy for chronic Achilles tendinopathy: a comparative cohort study." American Journal of Sports Medicine. 2023;51(4):982-991.
4. Santos-Vega M, et al. "Return-to-play outcomes after regenerative injection therapies in professional footballers." Knee Surgery, Sports Traumatology, Arthroscopy. 2021;29(8):2456-2464.

Dr. Santos-Vega serves as a Medical Reviewer for Klow Peptide, providing expert review of content related to regenerative peptides and sports medicine.

Her role includes:

• Scientific review of articles on BPC-157, TB-500, and tissue regeneration
• Verification of claims against current research evidence
• Ensuring accuracy of dosage information and safety considerations
• Advisory input on emerging regenerative therapies

Articles reviewed by Dr. Santos-Vega are marked with her credentials to indicate expert medical oversight.

Connect: LinkedIn Profile